Today, the Klinikum Ludwigshafen and the
German state
medical association of Rheinland Pfalz announced that 90 of 115 studies they examined lacked proper approval from an institutional review
board (IRB).
Ad hoc reviewer for several grant agencies including: Wellcome Trust, European Commission,
Medical Research Council of UK, Funding for Scientific Research of Belgium, National Research Agency of France, National Cancer Institute of France, the Broad Foundation for Scientific and
Medical Research of USA, Health Research
Board of Ireland, Italian Ministry of University and Research, Italian Ministry of Health, Italian National Institute of Health, Italian -
German University, Italian National Research Council, Al Neelain University of the Islamic Republic of Sudan, Cancéropôle Grand Ouest of the French government, Ministry of Health of the Czech Republic, Ministry of Science, Technology and Space State of the State of Israel, Cancer Research Wales, Kuwait University.
He is also Speaker of the Senate of the University of Heidelberg, as well as being a member of the Scientific Advisory
Board of the
German Medical Association and the
German Association of Psychotherapists.